GO:0006119 oxidative phosphorylation: Energy Conversion Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006119 oxidative phosphorylation is the biological process in which ADP is phosphorylated to ATP using energy derived from the oxidation of metabolites through the respiratory chain.
• The process is carried out by the mitochondrial electron transport chain (ETC) complexes I-IV, which establish a proton gradient across the inner mitochondrial membrane, and by ATP synthase (complex V), which uses that gradient to synthesize ATP.
• Oxidative phosphorylation is the dominant source of ATP in most aerobic cells and is therefore central to cellular bioenergetics, metabolism, and survival.
• Dysregulation of oxidative phosphorylation is implicated in viral infections, aging, and a broad range of metabolic and degenerative diseases.
• Key genes include both mitochondrial DNA-encoded subunits (e.g., MT-ND1, MT-CO1, MT-ATP6) and nuclear DNA-encoded subunits and assembly factors (e.g., NDUFS1, SDHA, UQCRC1, COX4I1, ATP5F1A).
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of oxidative phosphorylation gene function and are supported by EDITGENE services.
Description
Oxidative phosphorylation (GO:0006119) is the biological process that couples the oxidation of metabolites through the respiratory chain to the phosphorylation of ADP, producing the majority of cellular ATP in aerobic organisms. The term is defined in QuickGO as the phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain, where oxidation establishes a proton gradient across the membrane that provides the energy for ATP synthesis. This process is fundamental to mitochondrial bioenergetics and is conserved from bacteria to humans. For researchers, oxidative phosphorylation is a central node linking metabolism, redox biology, and cell fate. The electron transport chain (ETC) not only drives ATP production but also contributes to oxidant production and signaling. Consequently, oxidative phosphorylation is studied in contexts ranging from viral infection and immune metabolism to aging and degenerative disease. Understanding its molecular components, regulation, and disease associations is essential for both basic and translational research. This article provides a research-grade overview of GO:0006119, covering its definition, mechanism, key genes, regulation, disease relevance, and experimental methods, with an emphasis on CRISPR-based approaches for functional interrogation.
oxidative phosphorylation At A Glance
| GO ID | GO:0006119 |
|---|---|
| GO term | oxidative phosphorylation |
| Ontology | biological_process |
| Synonym | respiratory-chain phosphorylation |
| Definition | The phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis. |
| Major function | ATP synthesis driven by the proton gradient generated by the respiratory chain |
| Cellular location | Inner mitochondrial membrane in eukaryotes |
| Key complexes | ETC complexes I-IV and ATP synthase (complex V) |
| Related processes | Electron transport, proton gradient formation, ATP synthesis |
What Is GO:0006119?
In our own words, GO:0006119 oxidative phosphorylation is the process in which the energy released by oxidizing metabolites through the respiratory chain is used to phosphorylate ADP, forming ATP. Oxidation of compounds establishes a proton gradient across a membrane, and the controlled flow of protons back across that membrane provides the energy for ATP synthesis. This definition captures the essential coupling of electron transport to ATP production.
Why Is oxidative phosphorylation Important in Cell Biology?
Oxidative phosphorylation is the principal route of ATP production in aerobic cells and is therefore indispensable for cellular energy homeostasis, metabolism, and survival. Its dysfunction or dysregulation is linked to a wide spectrum of human conditions, including viral infections, aging-related decline, and metabolic and degenerative diseases. Because it sits at the intersection of bioenergetics, redox biology, and cell signaling, oxidative phosphorylation is a high-value target for both mechanistic research and therapeutic development.
• Provides the majority of ATP in aerobic cells, supporting all energy-dependent processes.
• Couples electron transport to ATP synthesis via the proton gradient, a fundamental bioenergetic mechanism.
• Contributes to cellular redox balance and oxidant production, influencing signaling and stress responses.
• Is modulated during viral infections, affecting host immunity and viral replication.
• Declines with age and is associated with slow-aging phenotypes in model organisms.
• Is implicated in mitochondrial diseases caused by mutations in ETC subunits or assembly factors.
• Serves as a target for drugs and metabolic interventions in cancer and metabolic disorders.
• Is essential for biosynthesis, ion homeostasis, and cell survival.
• Provides a model system for studying membrane bioenergetics and enzyme coupling.
• Offers opportunities for CRISPR-based functional genomics and therapeutic editing.
What Happens During oxidative phosphorylation?
Electron transport and proton pumping
In simple terms: Electrons are passed along a chain of protein complexes, and the energy released is used to pump protons across a membrane.
During oxidative phosphorylation, electrons derived from NADH and FADH2 are transferred through a series of respiratory chain complexes (complexes I-IV) located in the inner mitochondrial membrane. As electrons move through these complexes, the energy released is used to pump protons from the mitochondrial matrix to the intermembrane space, creating an electrochemical proton gradient. This step is the oxidation phase of the process and is essential for establishing the driving force for ATP synthesis.
Proton gradient formation
In simple terms: Protons are pushed to one side of the membrane, storing energy like water behind a dam.
The proton pumping by complexes I, III, and IV creates a proton motive force across the inner mitochondrial membrane, consisting of a chemical gradient (pH difference) and an electrical potential. This gradient represents the stored energy that will be used for ATP synthesis. The integrity of the membrane and the stoichiometry of proton pumping are critical for efficient energy conversion.
ATP synthesis by ATP synthase
In simple terms: Protons flow back through a molecular turbine, which spins and builds ATP.
Protons re-enter the mitochondrial matrix through ATP synthase (complex V), driving rotation of its c-ring and causing conformational changes in the catalytic subunits that lead to the phosphorylation of ADP to ATP. This is the phosphorylation phase of oxidative phosphorylation and is tightly coupled to the proton gradient. ATP synthase is a rotary motor enzyme whose mechanism has been extensively studied.
Coupling and regulation of the process
In simple terms: The two halves of the process are linked so that one cannot proceed without the other under normal conditions.
Oxidative phosphorylation is a coupled process: electron transport and ATP synthesis are interdependent, and uncoupling agents can dissipate the proton gradient and separate the two. The process is regulated by substrate availability, oxygen levels, ADP concentration, and various signaling pathways. In mammalian mitochondria, the oxidative phosphorylation system is organized into supercomplexes that may enhance efficiency and reduce oxidant production.
Key Genes Involved in GO:0006119 oxidative phosphorylation
The following genes encode core subunits and assembly factors of the oxidative phosphorylation machinery, representing key targets for functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MT-ND1 | Subunit of complex I (NADH dehydrogenase) | Mitochondrial DNA-encoded; mutations linked to mitochondrial diseases |
| MT-ND2 | Subunit of complex I | Involved in proton pumping and electron transfer |
| MT-CO1 | Subunit of complex IV (cytochrome c oxidase) | Catalytic core of complex IV; target for functional studies |
| MT-ATP6 | Subunit of ATP synthase (complex V) | Proton translocation and ATP synthesis; mutations cause neuropathy |
| NDUFS1 | Nuclear-encoded subunit of complex I | Assembly and stability of complex I; disease-associated |
| NDUFV1 | Nuclear-encoded subunit of complex I | Electron transfer; mutations cause complex I deficiency |
| SDHA | Subunit of complex II (succinate dehydrogenase) | Links TCA cycle to ETC; tumor suppressor context |
| UQCRC1 | Subunit of complex III (ubiquinol-cytochrome c reductase) | Electron transfer and proton pumping |
| CYC1 | Subunit of complex III | Cytochrome c binding and electron transfer |
| COX4I1 | Subunit of complex IV | Regulation of cytochrome c oxidase activity |
| COX5A | Subunit of complex IV | Assembly and stability of complex IV |
| ATP5F1A | Alpha subunit of ATP synthase | Catalytic subunit; ATP synthesis |
| ATP5F1B | Beta subunit of ATP synthase | Catalytic subunit; ATP synthesis |
| ATP5MC1 | Subunit of ATP synthase | Proton channel component |
| TFAM | Mitochondrial transcription factor A | Regulates mtDNA expression and oxidative phosphorylation capacity |
| POLG | Mitochondrial DNA polymerase | mtDNA replication and maintenance |
| PPARGC1A | PGC-1alpha, transcriptional coactivator | Regulates mitochondrial biogenesis and oxidative phosphorylation genes |
How Is oxidative phosphorylation Regulated?
Oxidative phosphorylation is regulated at multiple levels, including substrate supply, oxygen availability, ADP/ATP ratios, and transcriptional control of nuclear and mitochondrial genes. The process is also influenced by signaling pathways that respond to energy status, such as AMPK and mTOR, and by transcriptional coactivators like PGC-1alpha that promote mitochondrial biogenesis. In mammalian mitochondria, the organization of ETC complexes into supercomplexes can modulate efficiency and oxidant production. Additionally, oxidative phosphorylation is dynamically regulated during viral infections, where host and viral factors can alter ETC activity.
oxidative phosphorylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MT-ATP6 | Neuropathy, ataxia, and retinitis pigmentosa (NARP); Leigh syndrome | Point-mutation knock-in in cells or animal models |
| NDUFS1 | Complex I deficiency; Leigh syndrome | Knockout and rescue in cell lines |
| SDHA | Hereditary paraganglioma and pheochromocytoma | Knockout in cancer cell lines |
| COX4I1 | Cytochrome c oxidase deficiency | Knockout and overexpression models |
| PPARGC1A | Metabolic syndrome and aging-related decline | Overexpression and knockout in mice |
Mitochondrial diseases and ETC deficiencies
Mutations in genes encoding oxidative phosphorylation subunits or assembly factors can cause mitochondrial diseases with diverse clinical presentations, including encephalopathy, myopathy, and cardiomyopathy. These disorders often arise from impaired electron transport or ATP synthesis, leading to energy failure and increased oxidant stress. Both mitochondrial DNA and nuclear DNA mutations contribute to this disease spectrum.
Viral infections and immune metabolism
Oxidative phosphorylation is modulated during viral infections, and viruses can alter host mitochondrial bioenergetics to support replication or evade immune responses. Changes in ETC activity can influence interferon signaling and inflammatory pathways. Understanding these interactions may reveal therapeutic targets for antiviral strategies.
Aging and metabolic decline
Age-related decline in oxidative phosphorylation capacity is observed in various tissues, and slow-aging mouse models show preserved oxidative phosphorylation and fatty acid oxidation. This suggests that maintaining mitochondrial function may contribute to healthy aging. Interventions that enhance oxidative phosphorylation are being explored for age-related metabolic diseases.
From oxidative phosphorylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a specific ETC subunit impair oxidative phosphorylation? | CRISPR knockout cell lines |
| Does a disease-associated point mutation alter ATP synthesis? | CRISPR point-mutation knock-in |
| Can a tagged subunit be used to track complex assembly? | Tagged knock-in (e.g., GFP or HA) |
| Does overexpression of a subunit enhance respiratory capacity? | CRISPR overexpression or cDNA overexpression |
| Which genes are essential for oxidative phosphorylation in a given cell type? | CRISPR library screening |
| How does a mutation affect mitochondrial morphology and function? | Knockout plus imaging and respirometry |
How to Study the oxidative phosphorylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse respirometry | Oxygen consumption rates | Assessing oxidative phosphorylation activity in cells |
| Blue native PAGE | ETC complex assembly and supercomplexes | Detecting assembly defects |
| Enzyme activity assays | Individual complex activities | Diagnosing ETC deficiencies |
| RNA-seq | Gene expression changes | Identifying transcriptional regulation |
| CRISPR screening | Gene essentiality for oxidative phosphorylation | Discovery of novel regulators |
| Mitochondrial membrane potential dyes | Proton gradient integrity | Evaluating coupling and uncoupling |
| ATP luminescence assays | Cellular ATP levels | Measuring energy status |
| Immunoblotting | Protein levels of ETC subunits | Validating knockout or overexpression |
Respirometry and metabolic assays
Oxygen consumption rates are measured using Seahorse extracellular flux analyzers or Clark-type electrodes to assess oxidative phosphorylation activity in live cells or isolated mitochondria. These methods provide real-time readouts of basal and maximal respiration, ATP-linked respiration, and spare respiratory capacity.
Genomic and transcriptomic profiling
RNA-seq and mitochondrial DNA sequencing can identify expression changes and mutations in oxidative phosphorylation genes. CRISPR screening combined with sequencing enables systematic discovery of genes required for oxidative phosphorylation.
Proteomic and biochemical analyses
Blue native PAGE and immunoblotting are used to assess the assembly and abundance of ETC complexes and supercomplexes. Enzyme activity assays for individual complexes (I-IV) and ATP synthase provide functional validation.
Imaging and functional probes
Fluorescent probes for membrane potential, ATP, and reactive oxygen species allow spatial and temporal monitoring of oxidative phosphorylation in cells. Live-cell imaging of mitochondrial morphology complements functional assays.
How CRISPR Can Be Used to Study GO:0006119 oxidative phosphorylation
Knockout
CRISPR knockout of nuclear-encoded oxidative phosphorylation genes (e.g., NDUFS1, SDHA, COX4I1) can abolish specific ETC complex activity, enabling causal tests of subunit function and assembly. Knockout cell lines are valuable for studying compensatory mechanisms and drug sensitivity.
Point Mutation
CRISPR point-mutation knock-in allows introduction of disease-associated variants (e.g., in MT-ATP6 or NDUFS1) to model mitochondrial disease and assess functional consequences on ATP synthesis and oxidant production. This approach provides isogenic controls for precise genotype-phenotype mapping.
Knock-in
Tagged knock-in of oxidative phosphorylation subunits (e.g., GFP or HA tags) enables visualization and affinity purification of ETC complexes, facilitating studies of assembly, dynamics, and interactome. Knock-in of reporter cassettes can also be used to monitor promoter activity.
Overexpression
CRISPR activation or cDNA overexpression of oxidative phosphorylation genes (e.g., PPARGC1A) can enhance respiratory capacity and mitochondrial biogenesis, providing models to study metabolic remodeling and aging. Overexpression models are useful for testing sufficiency of a gene in driving oxidative phosphorylation.
How EDITGENE Supports oxidative phosphorylation Research
Researchers studying oxidative phosphorylation-related genes often need to determine whether a candidate gene is causally involved in mitochondrial function, ATP production, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for oxidative phosphorylation research.
Frequently Asked Questions About oxidative phosphorylation
What is oxidative phosphorylation GO:0006119?
GO:0006119 oxidative phosphorylation is the biological process in which ADP is phosphorylated to ATP using energy from the oxidation of metabolites through the respiratory chain, which establishes a proton gradient across the membrane.
What genes are involved in oxidative phosphorylation?
Key genes include mitochondrial DNA-encoded subunits such as MT-ND1, MT-CO1, and MT-ATP6, and nuclear DNA-encoded subunits and assembly factors such as NDUFS1, SDHA, UQCRC1, COX4I1, and ATP5F1A.
Where does oxidative phosphorylation occur?
In eukaryotes, oxidative phosphorylation occurs in the inner mitochondrial membrane, where the electron transport chain complexes and ATP synthase are located.
What is the role of the electron transport chain in oxidative phosphorylation?
The electron transport chain transfers electrons from NADH and FADH2 to oxygen, pumping protons across the inner mitochondrial membrane to create the gradient that drives ATP synthesis.
How is oxidative phosphorylation regulated?
It is regulated by substrate availability, oxygen levels, ADP/ATP ratios, and signaling pathways that control mitochondrial biogenesis and ETC complex assembly.
What diseases are associated with oxidative phosphorylation defects?
Defects are linked to mitochondrial diseases, neurodegenerative disorders, metabolic syndromes, and altered responses to viral infections.
How can CRISPR be used to study oxidative phosphorylation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of oxidative phosphorylation gene function and disease variants.
What methods measure oxidative phosphorylation activity?
Common methods include Seahorse respirometry, blue native PAGE, enzyme activity assays, and ATP luminescence assays.
Is oxidative phosphorylation affected by aging?
Yes, age-related decline in oxidative phosphorylation is observed, and slow-aging models show preserved oxidative phosphorylation and fatty acid oxidation.
What is the difference between oxidative phosphorylation and glycolysis?
Oxidative phosphorylation uses the respiratory chain and oxygen to produce ATP, while glycolysis breaks down glucose in the cytoplasm without oxygen; both contribute to cellular ATP.
Conclusion
GO:0006119 oxidative phosphorylation is a cornerstone of cellular energy metabolism, integrating electron transport, proton gradient formation, and ATP synthesis. Its dysfunction is implicated in a wide range of diseases, from mitochondrial disorders to viral infections and aging. Advances in CRISPR-based modeling and functional genomics are accelerating the dissection of oxidative phosphorylation gene function and the development of targeted interventions. EDITGENE provides the tools and expertise to support these efforts with precision and scale.
References
- 1. Nolfi-Donegan D et al.. 2020. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement.. Redox Biol 37:101674 PMID: 32811789
- 2. Purandare N et al.. 2023. Mitochondrial Oxidative Phosphorylation in Viral Infections.. Viruses 15(12) PMID: 38140621
- 3. Elmansi AM et al.. 2024. Oxidative phosphorylation and fatty acid oxidation in slow-aging mice.. Free Radic Biol Med 224:246-255 PMID: 39153667
- 4. Griffiths DE. 1965. Oxidative phosphorylation.. Essays Biochem 1:91-120 PMID: 4301986
- 5. KREBS HA et al.. 1953. Oxidative phosphorylation.. Biochem J 54(1):107-16 PMID: 13058839
- 6. LEHNINGER AL et al.. 1962. Oxidative phosphorylation.. Annu Rev Biochem 31:47-78 PMID: 14463786
- 7. Slater EC. 1977. Mechanism of oxidative phosphorylation.. Annu Rev Biochem 46:1015-26 PMID: 20036
- 8. Papa S et al.. 2012. The oxidative phosphorylation system in mammalian mitochondria.. Adv Exp Med Biol 942:3-37 PMID: 22399416
